InvestorsHub Logo
Followers 8
Posts 481
Boards Moderated 0
Alias Born 02/03/2021

Re: Normyshorts post# 176291

Thursday, 07/29/2021 4:32:57 PM

Thursday, July 29, 2021 4:32:57 PM

Post# of 232888
Actually that 8-k is comparing our data against a trial for another drug "SG". We do very well against SOC of that trial but comparably (in subgroups) against their main drug SG. But we don't know how their trial filtered for their patients. Also, Merck updated that Keytruda has passed PE for mTNBC. See their recent news.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News